<?xml version="1.0" encoding="UTF-8"?>
<p>Dengue virus (DENV), a mosquito-borne flavivirus, causes an estimated 390 million infections annually and presents a formidable burden on the global healthcare system [
 <xref rid="ppat.1007716.ref001" ref-type="bibr">1</xref>]. DENV infection can result in common dengue fever (DF) and more severe illnesses such as dengue hemorrhagic fever (DHF) and dengue shock syndrome (DSS). DHF and DSS are characterized by increased vascular permeability, hemorrhagic manifestations, and plasma leakage-induced shock that can lead to death. Approximately 40% of the worldâ€™s population lives in dengue-endemic regions, so the spread of DENV infection and threat of severe disease remain a significant challenge to global human health [
 <xref rid="ppat.1007716.ref002" ref-type="bibr">2</xref>,
 <xref rid="ppat.1007716.ref003" ref-type="bibr">3</xref>].
</p>
